2-苄氧基-6-溴萘 | 2234-45-9

• 物质功能分类: 化学试剂 - 有机试剂 - 多环化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 2-苄氧基-6-溴萘
• 英文名称: 6-benzyloxy-2-bromonaphthalene
• 英文别名: 2-benzyloxy-6-bromonaphthalene；[(6-bromo-2-naphthyl)oxy](phenyl)methane；2-bromo-6-phenylmethoxynaphthalene
• CAS: 2234-45-9
• 化学式: C₁₇H₁₃BrO
• mdl: MFCD01568856
• 分子量: 313.194
• InChiKey: QVVBDTXZESAKDU-UHFFFAOYSA-N

物化性质

• 熔点：
  112-113 °C
• 沸点：
  434.6±20.0 °C(Predicted)
• 密度：
  1.395±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.058
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2909309090
• 危险性防范说明：
  P264,P280,P302+P352,P305+P351+P338,P332+P313,P337+P313,P362
• 危险性描述：
  H315,H319
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Benzyloxy-6-bromonaphthalene
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Benzyloxy-6-bromonaphthalene
CAS number: 2234-45-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C17H13BrO
Molecular weight: 313.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-苄氧基-6-溴萘 在 potassium dihydrogenphosphate 、 potassium nitrososulfonate 作用下， 以 丙酮 为溶剂， 生成 6-Benzyloxy-naphthochinon-1,2
  参考文献：
  名称：

  Horner,L. et al., Chemische Berichte, 1965, vol. 98, p. 1233 - 1245

  摘要：

  DOI：
• 作为产物：
  描述：

  6-溴-2-萘酚 、 氯化苄 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.5h， 以86%的产率得到2-苄氧基-6-溴萘
  参考文献：
  名称：

  杂芳基取代的萘和结构改性的衍生物：CYP11B2的选择性抑制剂，用于治疗充血性心力衰竭和心肌纤维化。

  摘要：

  最近，我们提出抑制醛固酮合酶（CYP11B2）作为一种治疗充血性心力衰竭和心肌纤维化的新策略。在这项研究中，描述了杂芳基取代的萘和喹啉（1-31）的合成和生物学评估。制备化合物的关键步骤是铃木交叉偶联。使用人CYP11B2在体外确定化合物的活性，并评估对人类固醇生成酶CYP11B1，CYP19和CYP17的选择性。已鉴定出大量的CYP11B2高活性和选择性抑制剂。活性最高的抑制剂是6-氰基化合物8（IC50 = 3 nM），显示出竞争性的抑制类型（K（i）值= 1.9 nM）。发现6-乙氧基衍生物5是最具选择性的CYP11B2抑制剂（IC50 = 12 nM； K（i）值= 8 nM; CYP11B1 IC50 = 5419 nM；选择性因子= 451），显示没有对人CYP3A4（50 nM）和CYP2D6（20 nM）的抑制作用。使用我们的同源性建模的CYP11B2结构与所选化合物进行了

  DOI：

  10.1021/jm0503704

文献信息

• Ring-opening reactions of 1,4-diazabicyclo[2.2.2]octane (DABCO) derived quaternary ammonium salts with phenols and related nucleophiles
  作者：Nenad Maraš、Slovenko Polanc、Marijan Kočevar

  DOI：10.1039/c1ob06676e

  日期：——

  1,4-Diazabicyclo[2.2.2]octane (DABCO) has been evaluated as a starting material for the synthesis of 1-alkyl-4-(2-phenoxyethyl)piperazines and related derivatives. We found that 1-alkyl-1,4-diazabicyclo[2.2.2]octan-1-ium salts, resulting from the alkylation of DABCO, efficiently react with a variety of nucleophiles in polyethyleneglycol (PEG) or diglyme at high temperatures to give piperazine products

  1,4-二氮杂双环[2.2.2]辛烷（DABCO）已被评估为合成1-烷基-4-（2-苯氧基乙基）哌嗪及其相关衍生物的原料。我们发现，由DABCO烷基化产生的1-烷基-1,4-二氮杂双环[2.2.2] octan-1-ium盐可在高温下与聚乙二醇（PEG）或二甘醇二甲醚中的多种亲核试剂有效反应，得到亲核开环反应产生的哌嗪产物。发现当使用1-苄基-1,4-二氮杂双环[2.2.2] octan-1-ium盐时，苄基化副反应与较软的亲核试剂有关，而未观察到其他类型的烷基化。一锅法可使用苯酚或其他亲核试剂和DABCO，直接从伯醇，卤代烷或磺酸盐直接合成哌嗪。
• [EN] 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS<br/>[FR] DERIVES DE 2,6-QUINOLINYLE ET DE 2,6-NAPHTYLE, LEURS PROCEDES DE PREPARATION ET LEUR UTILISATION COMME INHIBITEURS DE VLA-4
  申请人：UCB SA

  公开号：WO2003093237A1

  公开（公告）日：2003-11-13

  The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals for the treatment of VLA-4 dependent inflammatory diseases such as for example asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, psoriasis, urticaria, pruritus, eczema, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis and atherosclerosis. Formula (I): wherein X is N or CH.

  本发明涉及式(I)的2,6-喹啉基和2,6-萘基衍生物，制备它们的方法，含有它们的药物组合物以及它们作为治疗VLA-4依赖性炎症性疾病的药物的用途，例如哮喘、过敏性鼻炎、鼻窦炎、结膜炎、食物过敏、牛皮癣、荨麻疹、瘙痒、湿疹、类风湿关节炎、炎症性肠病、多发性硬化和动脉粥样硬化等。式(I)：其中X为N或CH。
• Hydrodehalogenation of Haloarenes by a Sodium Hydride-Iodide Composite
  作者：Derek Yiren Ong、Ciputra Tejo、Kai Xu、Hajime Hirao、Shunsuke Chiba

  DOI：10.1002/anie.201611495

  日期：2017.2.6

  A simple protocol for hydrodebromination and ‐deiodination of halo(hetero)arenes was enabled by sodium hydride (NaH) in the presence of lithium iodide (LiI). Mechanistic studies showed that an unusual concerted nucleophilic aromatic substitution operates in the present process.

  在碘化锂（LiI）存在下，氢化钠（NaH）可以实现卤代（杂）芳烃加氢溴化和碘化的简单方法。机理研究表明，在当前过程中发生了异常的协同的亲核芳族取代。
• Optically active compound and photosensitive resin composition
  申请人：——

  公开号：US20030211421A1

  公开（公告）日：2003-11-13

  A photoactive compound is used in combination with a photosensitizer, represented by the following formula (1): A −[( J ) m −( X-Pro )] n (1) wherein A represents a hydrophobic unit comprising at least one kind of hydrophobic groups selected from a hydrocarbon group and a heterocyclic group, J represents a connecting group, X-Pro represents a hydrophilic group protected by a protective group Pro which is removable by light exposure, m represents 0 or 1, and n represents an integer of not less than 1. The protective group Pro may be removable by light exposure in association with the photosensitizer (especially, a photo acid generator), or may be a hydrophobic protective group. The hydrophilic group may be a hydroxyl group or a carboxyl group. The photoactive compound has high sensitivity to a light source of short wavelength beams, for resist application, therefore, the photoactive compound is advantageously used for forming a pattern with high resolution.

  一种光活性化合物与光敏剂结合使用，由以下公式（1）表示： A −[( J ) m −( X-Pro )] n (1) 其中，A代表至少包括一种从烃基和杂环基中选择的疏水基的疏水单元，J代表连接基团，X-Pro代表由光照可去除的保护基团Pro保护的亲水基团，m代表0或1，n代表不少于1的整数。 保护基团Pro可以与光敏剂（特别是光酸发生剂）一起通过光照可去除，也可以是疏水保护基团。亲水基团可以是羟基或羧基。光活性化合物对短波长光源具有很高的敏感性，用于光刻应用，因此，该光活性化合物有利于形成具有高分辨率的图案。
• Naphthyloxazolidone derivatives
  申请人：Tanabe Seiyaky Co., Ltd.

  公开号：US05182296A1

  公开（公告）日：1993-01-26

  A naphthyloxazolidone derivative of the formula: ##STR1## wherein R.sup.1 is hydrogen atom, hydroxy group, nitro group, amino group, sulfo group, aminosulfoyul group, a lower alkenyloxy group, a lower alkynyloxy group, a mono or di(lower alkyl)aminocarbonyloxy group, a lower alkanoyloxy group or a lower alkoxy group which may have a substituent selected from an aryl group, a cycloalkyl group, an oxygen-containing heteromonocyclic group, hydroxy group, a lower alkoxy group, cyano group, a di(lower alkyl)amino group, aminocarbonyl group, a lower alkoxycarbonyl group, a lower alkanoyloxy group, a lower alkylthio group, a lower alkylsulfinyl group and a lower alkylsulfonyl group; R.sup.2 is hydroxy group, a lower alkoxy group, a lower alkylsulfonyloxy group, triazo group or an amino group which may have a substituent selected from a lower alkyl group and a lower alkanoyl group, and a pharmaceuticaly acceptable salt thereof are disclosed. Said derivative and a pharmaceutically acceptable salt thereof are useful as an antidepressant.

  一种公式为：##STR1##的萘氧噁唑酮衍生物，其中R.sup.1是氢原子、羟基、硝基、氨基、磺酰基、氨基磺酰基、较低的烯氧基、较低的炔氧基、单或双(较低烷基)氨基羰氧基、较低的烷酰氧基或较低的烷氧基，可能具有从芳基、环烷基、含氧杂环基、羟基、较低烷氧基、氰基、二(较低烷基)氨基、氨基羰基、较低烷氧羰基、较低烷酰氧基、较低烷硫基、较低烷基亚砜基和较低烷基砜基中选择的取代基；R.sup.2是羟基、较低烷氧基、较低烷基砜基氧基、三唑基或氨基，可能具有从较低烷基和较低烷酰基中选择的取代基，以及其药学上可接受的盐。所述衍生物及其药学上可接受的盐可用作抗抑郁药。

表征谱图